↓ Skip to main content

Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies

Overview of attention for article published in Cardiovascular Diabetology, May 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Readers on

mendeley
71 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies
Published in
Cardiovascular Diabetology, May 2014
DOI 10.1186/1475-2840-13-94
Pubmed ID
Authors

Campbell Howard, Adele Noe, Andrej Skerjanec, Björn Holzhauer, Margaret Wernsing, Monica Ligueros-Saylan, Tom Thuren

Abstract

We aimed to assess the safety and tolerability of different doses of canakinumab versus placebo in patients with type 2 diabetes mellitus (T2DM).

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 1%
Unknown 70 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 14 20%
Student > Master 10 14%
Student > Ph. D. Student 8 11%
Professor 4 6%
Student > Doctoral Student 4 6%
Other 14 20%
Unknown 17 24%
Readers by discipline Count As %
Medicine and Dentistry 32 45%
Agricultural and Biological Sciences 6 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Nursing and Health Professions 3 4%
Immunology and Microbiology 1 1%
Other 5 7%
Unknown 21 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 May 2014.
All research outputs
#16,722,190
of 25,374,917 outputs
Outputs from Cardiovascular Diabetology
#1,001
of 1,653 outputs
Outputs of similar age
#139,049
of 241,445 outputs
Outputs of similar age from Cardiovascular Diabetology
#12
of 24 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,653 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 241,445 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.